The patients are randomized 1:1 to routine follow up for 3 years with regular doctors´ appointments according to national guidelines and the same follow up but with the addition of whole body CT or Positron Emission Tomography (PET) scans and blood tests. An interim analysis will be conducted when 1000 patients have been included.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
At least 18 years of age.
Radical surgery for Cutaneous Malignant Melanoma (CMM) stage IIb-c and III.
Sufficient renal function for i.v. contrast scannings.
You may not be if
The patient is assessed as unfit to receive treatment in the case of recurrence.
Life-expectancy less than 2 years due to concurrent disease (e.g., cardiac disease, terminal multiple sclerosis, liver cirrhosis).
Inability to provide informed consent or refusal to do so.
Inability to comply with the control or intense follow-up program.
Participation in other clinical trials interfering with the control-program.
Existing or previous malignancies within the past 5 years (except for in situ breast and cervical cancer, melanoma in situ and non-melanoma skin cancer).
Pregnancy or currently planned pregnancy.
Clareo Health | A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma
